Anxiety, Chemotherapy Effect, Fatigue, Laughter, Nausea, Vomiting
Conditions
Brief summary
This study was conducted to investigate the effect of video playback of children's laughter on anxiety, nausea, vomiting and fatigue levels of patients during chemotherapy
Detailed description
Nausea and vomiting, anxiety and fatigue due to chemotherapy can be prevented or reduced with effective nursing interventions and care. Laughter therapy is an intervention that has been used in the symptom management of individuals with cancer in recent years. Studies focusing on humor and laughter have generally been conducted among cancer patients. Humor and laughter have been shown to have both physiological, psychological and sociological benefits for patients in general. When the studies on laughter yoga are examined, it is seen that the results of laughter therapy applied to individuals are examined. It has also been reported in the literature that laughter has a contagious effect, often occurring in groups of people. There is no study in the literature on the effect of children's laughter on adults. This study will reveal the effectiveness of infant and child laughter in patients receiving chemotherapy. It is thought that this study will constitute an important data source for experimental studies to be conducted.
Interventions
BEHAVIORALChild laughter video
1 hour after the chemotherapy treatment was started, the video monitor was placed at a height where the patient could see comfortably while lying down and the video, which was checked and prepared beforehand, was turned on full screen. The appropriate volume was adjusted and the patient was allowed to watch the video for 10 minutes without any other intervention. The video was then stopped and the etagere was removed from in front of the patient. Chemotherapy was continued. At the 2nd hour of chemotherapy, the disinfected etagere and computer were placed in a position where the patient could see them comfortably and the 2nd video was started and the patient was allowed to watch the video for 10 minutes.
Sponsors
Selcuk University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
32 Years to 81 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed with lymphoma (preferred to have the same type of cancer) * Receiving the R - Chop cycle protocol as chemotherapy (This cycle was preferred because of the nausea and vomiting experienced in this protocol and the duration of the treatment is 4-5 hours) (Cleveland Clinic 2025). * Inpatient hospitalization, * Be over 18 years of age, * Conscious, oriented and cooperative
Exclusion criteria
* Don't take a different cure than R - Chop, * Visual and hearing and cognitive impairment, * Do not have a problem that creates a communication barrier, * Having any psychiatric illness such as depression, euphoria and taking psychiatric medication * Refusal to participate in the study * Other non-pharmacological methods
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vomiting Follow-up Form | As soon as chemotherapy is started (Within first five minute) | With this form, the presence or absence of the patient's vomiting was questioned. Vomiting was first measured at the start of chemotherapy |
| FACIT Fatigue Scale | First measurement- 1 minutes before the start of the patient's chemotherapy | Developed by Singh in 2014, the scale was developed to evaluate the relationship between anemia and fatigue in cancer patients and to meet the increasing demand. This form was applied in the pre-test and post-test phase. |
| Physiological Parameter Follow-up Form (Heart rate-min) | As soon as chemotherapy is started (Within first five minute) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. |
| Physiological Parameter Follow-up Form (Respiration rate- min) | As soon as chemotherapy is started (Within first five minute) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | As soon as chemotherapy is started (Within first five minute) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | As soon as chemotherapy is started (Within first five minute) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. |
| Nausea Follow-up Form | As soon as chemotherapy is started (Within first five minute) | With this form, the presence or absence of the patient's nause was questioned.Nausea was first measured at the start of chemotherapy |
| Patient information form | First measurement-10. minutes before the start of the patient's chemotherapy | The form was designed by the researchers in two parts to assess personal characteristics and characteristics related to the disease and treatment. |
| Spielberger State Anxiety Scale | First measurement- 5 minutes before the start of the patient's chemotherapy | The scale measures the level of status anxiety of the patient with 20 questions.this form was applied in the pre-test and post-test phase |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Physiological Parameter Follow-up Form (Respiration rate- min) | Second measurement: 1. hour after starting chemotherapy | The measurement was made immediately after the first hour was full. |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | Second measurement: 1. hour after starting chemotherapy | The measurement was made immediately after the first hour was full. |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | Second measurement: 1. hour after starting chemotherapy | The measurement was made immediately after the first hour was full. |
| Nausea Follow-up Form | Second measurement: 1. hour after starting chemotherapy | The measurement was made immediately after the first hour was full. |
| Vomiting Follow-up Form | Second measurement: 1. hour after starting chemotherapy | The measurement was made immediately after the first hour was full. |
| Physiological Parameter Follow-up Form (Heart rate-min) | Second measurement: 1. hour after starting chemotherapy | The measurement was made immediately after the first hour was full. |
Countries
Turkey (Türkiye)
Outcome results
None listed